NL-OMON35292已完成不适用
OPEN LABEL PHASE I STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSES OF KETOCONAZOLE ON THE SINGLE-DOSE PHARMACOKINETICS OF TASQUINIMOD IN HEALTHY SUBJECTS - Ketoconazole * Tasquinimod Interaction Study
PRA International EDS0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male and female volunteers
- •Age: 18-55 years, inclusive
- •BMI: 18.0 * 30.0 kg/m2, inclusive
排除标准
- •- Suffering from hepatitis B, cancer or HIV/AIDS
- •- In case of participation in another drug study within 60 days before the start of this study
- •- In case of donation of more than 50 ml of blood within 60 days prior to drug administration
- •- Donation of more than 1.5 L of blood (for men) / more than 1.0 L of blood (for women) in the 10 months preceding the start of the study
研究者
相似试验
已完成
不适用
OPEN LABEL PHASE I STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSES OF RIFAMPICIN ON THE SINGLE-DOSE PHARMACOKINETICS OF TASQUINIMOD IN HEALTHY SUBJECTS1002765610036958prostate cancerNL-OMON35265PRA International EDS12
未知
不适用
AN OPEN LABEL, PHASE I STUDY TOEVALUATE THE IMPACT OF SEVERE HEPATICIMPAIRMENT ON THE PHARMACOKINETICSAND SAFETY OF VEMURAFENIB IN BRAFV600MUTATION POSITIVE CANCER PATIENTS-C43 Malignant melanoma of skin-C44 Other malignant neoplasms of skinMalignant melanoma of skinOther malignant neoplasms of skinC43C44PER-052-13F. HOFFMANN-LA ROCHE LTD.,
进行中（未招募）
1 期
Evaluation of efficacy and safety of standard chemotherapy in combination with Nilotonib in patients of 55 years and older with Philadelphia chromosome positive Acute Lymphoblastic Leukemia.Philadelphia chromosome positive Acute Lymphoblastic Leukemia inelderly patients (55 years and older)MedDRA version: 14.1Level: LLTClassification code 10000845Term: Acute lymphoblastic leukemiaSystem Organ Class: 100000004864EUCTR2010-022855-46-ITAzienda ULSS 12 veneziana55
进行中（未招募）
不适用
AN OPEN LABEL PHASE II STUDYTO EVALUATE THE EFFICACY AND SAFETY OF INDUCTION ANDCONSOLIDATION THERAPY WITH DASATINIB IN COMBINATION WITHCHEMOTHERAPY IN PATIENTS AGED 55 YEARS AND OVER WITHPHILADELPHIA CHROMOSOME POSITIVE (PH+ OR BCR-ABL+) ACUTELYMPHOBLASTIC LEUKEMIA (ALL). - NDPhiladelphia chromosome positive acute lymphoblasticleukaemiaMedDRA version: 9.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaMedDRA version: 9.1Level: HLTClassification code 10024290Term: Leukaemias acute lymphocyticEUCTR2006-005694-21-ITHOPITAL MIGNOT55
已完成
不适用
A Phase I, Open-Label Study to Determine the Effect of Repeat Dosing of Trametinib on the Pharmacokinetics of a Combined Oral Contraceptive (Norethindrone plus Ethinyl Estradiol) in Female Patients with Solid TumorsSolid tumorsSolid tumors with a BRAF V600 mutation10027655NL-OMON47513ovartis2